Clinical Trials Browser

Phase 1/2 × Unknown × Leukemia, Myelomonocytic, Chronic × Clear all

NCT04358393 2024-02-01

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT03040401 2017-12-19

A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic

NCT01368757 2015-03-09

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic